Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Proc Eur Dial Transplant Assoc1
Search Results
Sort by
- BookDavid Schiff, Isabel Arrillaga, Patrick Y. Wen, editors.Summary: "This updated edition provides clinicians from various backgrounds and levels of training the information needed to optimally diagnose and manage neurologic complications of the nervous system. Organized into seven sections, this comprehensive volume begins with an overview of diagnostic studies for neurologic complications involving the nervous system. That is followed by sections on metastatic and non-metastatic complications of cancer involving the nervous system, and the interpretation, diagnosis, and management of common neuro-oncologic symptoms. The next section reviews the neurologic complications of cancer therapy, including corticosteroids, radiation therapy, chemotherapy, targeted molecular therapies, immunotherapies, hematopoietic stem cell transplantation, and infections involving the nervous system. The final section focuses on the most important neurologic complications in cancers arising from specific organs. In addition to capturing the latest advancements in the rapidly evolving fields of oncology and cancer neurology, the goal of this resource is to lead clinicians toward prompt diagnosis and intervention in order to improve patient quality of life"--Publisher's description.
Contents:
Part I: Overview. The prevalence and impact of neurological disease in cancer
Part II: Diagnostic studies. Imaging neurologic manifestations of oncologic disease
Other diagnostic tools for neurological disease in cancer: EEG, EMG, and lumbar puncture
Part III: Nervous system involvement of systemic cancers. Brain metastasis as complication of systemic cancers
Leptomeningeal metastasis as complication of systemic cancers
Spinal metastasis as complication of systemic cancers
Peripheral nervous system metastases as complications of systemic cancers
Part IV: Neurological complications of cancer. Headache as complication of cancer
Seizures as complications in cancer
Cerebrovascular complications of cancer
Elevated intracranial pressure and hydrocephalus in brain tumor patients
Cognitive dysfunction, mood disorders, and fatigue as complications of cancer
Paraneoplastic syndromes of the nervous system as complications of cancer
Part V: Neurological complications of cancer therapy
Neurologic complications of radiation therapy
Neurological complications of chemotherapy
Neurological complications of targeted therapies
Neurological complications of immune-based therapies
Neurological complications of hematopoietic stem cell transplantation
Neurologic complications of corticosteroids in cancer therapy
Central nervous system infections in patients receiving cancer therapies
Part VI: Neurological complications of specific malignancies. Neurological complications of primary brain tumors
Neurological complications of lung cancer
Neurological complications of breast cancer and its treatment
Neurological complications of gastrointestinal cancer
Neurologic complications of genitourinary cancer
Neurologic complications of female reproductive tract cancers
Neurological complications of sarcomas
Neurological complications of head and neck cancer
Neurological complications of malignant melanoma
Neurological complications of leukemia
Neurologic complications of lymphoma
Neurologic complications of plasma cell dyscrasias
Neurologic complications of pediatric systemic cancer
Part VII: Neurological complications in long term cancer survivors. Neurological complications of cancer and cancer therapies in long term survivors.Digital Access Springer 2018 - ArticleSelwood NH.Proc Eur Dial Transplant Assoc. 1977;14:296-301.Follow-up data collected by the EDTA Registration Committee have been linked to donor and transplant information recorded by UK Transplant by forming a 'data interface' between the two Registries. The joint data have been used to study the fate of 243 pairs of kidneys used for first cadaver grafts in 1975 and 1976. The results of this preliminary study suggest that the transportation of kidneys and the cause of donor death do not affect graft survival. With a very small amount of data, analysis of the cause of failure suggests that this is not influenced by donor origins. The clinical condition at the time of grafting does not appear to have a major influence on the outcome of the graft. There seems little evidence to support the hypothesis that kidneys from the same donor share the same post-grafting fate.